Discovery of potential antiviral compounds against Dengue virus using virtual screening and physicochemical profiling from zinc database
African Journal of Clinical and Experimental Microbiology · 2026 · 27 (2) · 126-133
DOI: 10.4314/ajcem.v27i2.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift African Journal of Clinical and Experimental Microbiology, 2026. Verfasst von S. J. Ramdeen und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Dengue, a mosquito-borne virus infection, reportedly affected over 7.6 million people in early 2024, subsequently leading to approximately 3000 deaths. Dengue is primarily spread by Aedes (A. aegypti and A. albopictus) mosquitoes. There is currently no clinically approved preventive vaccine against Dengue virus (DENV), and according to the Center for Disease Control (CDC), the only acceptable vaccine for DENV is Dengvaxia, which has efficacy and safety issues. This makes it unsuitable for use against DENV. Drug repurpose is an alternative approach for the discovery of novel therapeutics.Methodology: In this study, we screened over one million compounds in the zinc database against the DENV NS2B/NS3 protease (PDB ID: 2FOM). Screening yielded about 122 compounds with potential activity against DENV. Among the 122 compounds, the top four were selected based on their docking scores and commercial availability. The cytotoxicity study showed that a concentration of up to 100 µM was non-toxic. Based on the cytotoxicity results, we selected non-toxic concentrations (500nM, 1µM, 10µM, and 20µM) to test against DENV2 infection. The results were analyzed using RT-qPCR and plaque assays.
Results
Compound treatment before DENV2 infection leads to a significant reduction in viral replication, which confirms the screening result. This gives a promising platform against DENV2 therapy.
Conclusion
This shows a significant step towards the discovery of an antiviral drug against the dengue virus
Zitieren
APA
Ramdeen, S. J., Usoro, N., Giordano, K., Garza, P. E., Quadri, P., Esan, T. E., & Olanrewaju, A. A. (2026). Discovery of potential antiviral compounds against Dengue virus using virtual screening and physicochemical profiling from zinc database. African Journal of Clinical and Experimental Microbiology, 27(2), 126-133. https://doi.org/10.4314/ajcem.v27i2.1
Vancouver
Ramdeen SJ, Usoro N, Giordano K, Garza PE, Quadri P, Esan TE, et al. Discovery of potential antiviral compounds against Dengue virus using virtual screening and physicochemical profiling from zinc database. African Journal of Clinical and Experimental Microbiology. 2026;27(2):126-133. doi:10.4314/ajcem.v27i2.1
BibTeX
@article{Ramdeen2026,
author = {Ramdeen, S. J. and Usoro, N. and Giordano, K. and Garza, P. E. and Quadri, P. and Esan, T. E. and Olanrewaju, A. A.},
title = {Discovery of potential antiviral compounds against Dengue virus using virtual screening and physicochemical profiling from zinc database},
journal = {African Journal of Clinical and Experimental Microbiology},
year = {2026},
volume = {27},
number = {2},
pages = {126--133},
doi = {10.4314/ajcem.v27i2.1}
}
EUVIMED